Effects of calcium antagonism and HMG-coenzyme reductase inhibition on endothelial function and atherosclerosis: Rationale and outline of the ENCORE trials

European Heart Journal, Supplement

Volumn 1, Issue M, 1999, Pages

  Sutsch, G ^a   Buchi, M ^a   Zeiher, A M ^a   Meinertz, T ^a   Hugenholtz, P G ^a   Jenni, R ^a   Rafflenbeul, W ^a   Drexler, H ^a   Haussmann, D ^a   Noll, G ^a   Quitzau, K ^a   Luscher, T F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cerivastatin; Coronary artery disease; Endothelial function; Nifedipine

Indexed keywords

ACETYLCHOLINE; ADENOSINE; CALCIUM ANTAGONIST; CERIVASTATIN; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; PLACEBO; STATIN;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BRAIN CIRCULATION; CALCIUM ANTAGONISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DEVICE; DISEASE COURSE; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; FOLLOW UP; HUMAN; INTRACORONARY INFUSION; INTRAVASCULAR ULTRASOUND; KIDNEY CIRCULATION; MAJOR CLINICAL STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0032809006     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)